Inventor · disambiguated record
Belinda Sánchez Ramírez
Also filed as: SANCHEZ RAMIREZ BELINDA · SÁNCHEZ RAMÍREZ BELINDA
4 granted patents·7 pending applications·9 citations·filing 2001–2024
64Inventor score
Files withCT INMUNOLOGIA MOLECULAR6INST FINLAY DE VACUNAS2CENTRO INMUNOLOGIA MOLECULAR1CT DE IMMUNOLOGIA MOLECULAR1INST FINALY DE VACUNAS1
Top patents by PatentIndex Score
11 records- 0173US11806396B2Nano-particles that contain synthetic variants of GM3 ganglioside as adjuvants in vaccinesCT INMUNOLOGIA MOLECULAR·Filed 2018·Granted Nov 7, 2023·1 cites·18 claims
- 0269US12280109B2Nano-particles that contain synthetic variants of GM3 ganglioside as adjuvants in vaccinesCT INMUNOLOGIA MOLECULAR·Filed 2023·Granted Apr 22, 2025·0 cites·24 claims
- 0364US7776342B2Preparations that potentiate immunogenicity in low immunogenic antigensCT DE IMMUNOLOGIA MOLECULAR·Filed 2001·Granted Aug 17, 2010·8 cites·13 claims
- 0457US2024299518A1Method for the treatment of patients with carcinomasCT INMUNOLOGIA MOLECULAR·Filed 2024·Application pending·0 cites
- 0548US2024042013A1Use of vaccine compositions based on sars-cov-2 receptor binding domain in delivering protective immunityINST FINLAY DE VACUNAS·Filed 2021·Application pending·0 cites
- 0645US12019073B2Method for the treatment of patients with carcinomasCT INMUNOLOGIA MOLECULAR·Filed 2018·Granted Jun 25, 2024·0 cites·3 claims
- 0745US2016166667A1Divalent vaccine compositions and the use thereof for treating tumorsCENTRO INMUNOLOGIA MOLECULAR·Filed 2014·Application pending·0 cites
- 0844US2023381295A1Covalent conjugates of the sars-cov-2 receptor-binding domain and a carrier protein and vaccine compositions that contain themINST FINLAY DE VACUNAS·Filed 2021·Application pending·0 cites
- 0944US2019275132A1Divalent vaccine compositions and the use thereof for treating tumorsCT INMUNOLOGIA MOLECULAR·Filed 2019·Application pending·0 cites
- 1043US2023226163A1Inorganic nanoparticle-based vaccine compositions for cancer treatmentCT INMUNOLOGIA MOLECULAR·Filed 2021·Application pending·0 cites
- 1139US2023330213A1Compositions of sars-cov-2 vaccines based on the receptor binding domain, expressed as a dimer, and the outer membrane vesicle of meningococcal group b bacteriaINST FINALY DE VACUNAS·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Belinda Sánchez Ramírez files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →